- Research works
- 24 ▲ 184% vs 2018-21
- Citations
- 410 16.8 per fractional work
- Top-10% rate
- 9.0% all institutions 10.0%
- Open access
- 19% world 40%
- International
- 22% world 18%
Not ranked overall: Barricaid (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Barricaid (United States) work in?
In all years, 57% of research at Barricaid (United States) is in Health Sciences, 28% in Life Sciences. Its largest fields are Medicine (55%), Biochemistry, Genetics and Molecular Biology (20%), Immunology and Microbiology (6%). It does 1.9× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 12 fields, with their numbers
- Health Sciences1457.0%
- Medicine1354.6%
- Dentistry02.0%
- Health Professions00.4%
- Life Sciences728.0%
- Physical Sciences210.2%
- Environmental Science14.1%
- Engineering13.1%
- Chemistry12.9%
- Social Sciences14.8%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 12.6×. Every wedge is a field page.
All 8 fields, with their numbers
- Immunology and Microbiology12.56×1 works
- Biochemistry, Genetics and Molecular Biology5.04×3 works
- Medicine2.45×5 works
- Chemistry2.13×0 works
- Dentistry1.38×0 works
- Neuroscience0.62×0 works
- Social Sciences0.40×0 works
- Engineering0.22×0 works
Which keywords describe research at Barricaid (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Surgical Treatment, Low Back Pain, Cancer Immunotherapy, Immunotherapy, Tumor Regression, Degenerative Disc Disease, Intervertebral Disc and Lumbar Disc Degeneration.
- Chronic Pain
- Bacterial Therapy
- Dendritic Cells
- Acetabular Fractures
- Immunity
- Innate Immunity
- Complications
- CAR T Cells
- Lumbar Disc Degeneration
- Degenerative Disc Disease
- Immunotherapy
- Low Back Pain
- Surgical Treatment
- Cancer Immunotherapy
- Tumor Regression
- Intervertebral Disc
- Epidemiology
- Chimeric Antigen Receptor
- Tumor Microenvironment
- Immune Checkpoint Blockade
- PD-1 and PD-L1
- Antigen Presentation
- Pelvic Fractures
- Biosensors
- Tumor Targeting
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 25 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 25 words, with their numbers
- Surgical Treatment4▲ 72×2 topics
- Low Back Pain3▲ 82×2 topics
- Cancer Immunotherapy3▲ 90×2 topics
- Immunotherapy3▲ 19×3 topics
- Tumor Regression3▲ 137×2 topics
- Degenerative Disc Disease2▲ 114×2 topics
- Intervertebral Disc2▲ 152×1 topic
- Lumbar Disc Degeneration2▲ 152×1 topic
- Epidemiology2▲ 2.4×6 topics
- CAR T Cells2▲ 181×1 topic
- Chimeric Antigen Receptor2▲ 181×1 topic
- Complications2▲ 14×3 topics
- Tumor Microenvironment1▲ 16×2 topics
- Innate Immunity1▲ 15×2 topics
- Immune Checkpoint Blockade1▲ 89×1 topic
- Immunity1▲ 15×2 topics
- PD-1 and PD-L11▲ 89×1 topic
- Acetabular Fractures1▲ 182×1 topic
- Antigen Presentation1▲ 47×1 topic
- Dendritic Cells1▲ 41×1 topic
- Pelvic Fractures1▲ 182×1 topic
- Bacterial Therapy1▲ 93×1 topic
- Biosensors1▲ 7.2×2 topics
- Chronic Pain1▲ 18×3 topics
- Tumor Targeting1▲ 31×1 topic
Which research topics does Barricaid (United States) publish most on?
By volume in 2022-now: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses and Cancer Research and Treatments.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 2 works
- 2 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 3 Immunotherapy and Immune Responses Immunology 1 works
- 4 Cancer Research and Treatments Biotechnology 1 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
- 6 Forensic Fingerprint Detection Methods Safety Research 0 works
- 7 Extracellular vesicles in disease Molecular Biology 0 works
- 8 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
- 9 Click Chemistry and Applications Organic Chemistry 0 works
- 10 Biosensors and Analytical Detection Biomedical Engineering 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Barricaid (United States)'s research output changed?
Output in 2022-2025 was 184% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Barricaid (United States) as a percentage of every work published that year, 0.000049% in 2024.
Fractional works of Barricaid (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Woburn
- GEI Consultants
- Scientific Systems (United States)
- Skyworks Solutions (United States)
- Microscale (United States)
- Aptima (United States)
- Frequency Therapeutics (United States)
- Systems and Technology Research (United States)
- Magnolia Solar (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Barricaid (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.